Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: TAP Pharmaceutical Products, Inc.
Current Parent Company: Takeda Pharmaceutical
Penalty: $25,516,440
Year: 2001
Date: October 5, 2001
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Mega-Scandal: Drug Pricing Abuses
Violation Description: TAP Pharmaceutical Products agreed to pay $25 million to settle multistate litigation alleging that it failed to provide state Medicaid programs the best price as required by law and that it improperly marketed its prostate cancer drug Lupron. This was part of a larger $875 million civil and criminal settlement involving the federal government; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Japan
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.